Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorGRASSET, Leslie
dc.contributor.authorZEKI AL HAZZOURI, Adina
dc.contributor.authorMILAZZO, Floriana
dc.contributor.authorLU, Peiyi
dc.contributor.authorELFASSY, Tali
dc.contributor.authorELBEJJANI, Martine
dc.contributor.authorVITTINGHOFF, Eric
dc.contributor.authorYAFFE, Kristine
dc.date.accessioned2024-11-19T12:27:19Z
dc.date.available2024-11-19T12:27:19Z
dc.date.issued2024-07-01
dc.identifier.issn1526-632Xen_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/203351
dc.description.abstractEnThe nature of associations between depressive symptoms and cognition early in the life course remains unclear, and racial differences in these associations are not well characterized. The aim of this study was to examine the relationship between trajectories of depressive symptom over 20 years, beginning in young adulthood, and cognitive functions in middle-age among Black and White adults. We used prospective data from participants of the Coronary Artery Risk Development in Young Adults Study. Depressive symptoms were measured at 5 study visits between 1990 and 2010 using the Center for Epidemiologic Studies Depression scale. We used latent class group-based modeling to identify 4 trajectories: "persistently low," "persistently medium," "medium decreasing," and "high increasing" depressive symptoms. In 2015, cognitive function was measured using the Digit Symbol Substitution Test (DSST), Stroop test (reverse coded), and Rey Auditory-Verbal Learning Test (RAVLT).We excluded participants who missed the cognitive battery or had no depressive symptoms measurements, resulting in a total of 3,117 participants. All cognitive tests were standardized, and linear regression was used to relate depressive trajectories with 2015 cognitive functions. The mean [SD] baseline age was 30.1 [3.6] years, and 57% were female. The associations between depressive symptoms and cognition significantly differed by race ( < 0.05). Among Black individuals, compared with having "persistently low," having "medium decreasing," "persistently medium," or "high increasing" depressive symptoms were associated with worse verbal memory, processing speed, and executive function scores (RAVLT persistently medium vs low: β = -0.30, 95% CI -0.48 to -0.12; and high increasing vs low: β = -0.49, 95% CI -0.70 to -0.27; DSST persistently medium vs low: β = -0.28, 95% CI -0.47 to -0.09; and high increasing vs low: β = -0.64, 95% CI -0.87 to -0.42; Stroop persistently medium vs low: β = -0.46, 95% CI -0.70 to -0.23; and high increasing vs low: β = -0.76, 95% CI -1.04 to -0.47). Associations were slightly weaker among White individuals, but we still found that having 'high increasing' depressive symptoms was associated with worse verbal memory and processing speed scores (high increasing vs low: β = -0.38, 95% CI -0.61 to -0.15; and β = -0.40, 95% CI -0.63 to -0.18, respectively). Prolonged exposure to elevated depressive symptoms beginning in young adulthood may result in worse cognitive function over midlife. This association was stronger among Black adults.
dc.language.isoENen_US
dc.subject.enHumans
dc.subject.enFemale
dc.subject.enMale
dc.subject.enDepression
dc.subject.enAdult
dc.subject.enWhite People
dc.subject.enMiddle Aged
dc.subject.enCognition
dc.subject.enNeuropsychological Tests
dc.subject.enProspective Studies
dc.subject.enBlack or African American
dc.subject.enYoung Adult
dc.subject.enLongitudinal Studies
dc.subject.enCognitive Dysfunction
dc.title.enLong-Term Depressive Symptom Trajectories and Midlife Cognition: The CARDIA Study
dc.title.alternativeNeurologyen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1212/WNL.0000000000209510en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed38865677en_US
bordeaux.journalNeurologyen_US
bordeaux.pagee209510en_US
bordeaux.volume103en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamVINTAGE_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDNational Heart, Lung, and Blood Instituteen_US
bordeaux.import.sourcepubmed
hal.identifierhal-04790815
hal.version1
hal.date.transferred2024-11-19T12:27:21Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Neurology&amp;rft.date=2024-07-01&amp;rft.volume=103&amp;rft.issue=1&amp;rft.spage=e209510&amp;rft.epage=e209510&amp;rft.eissn=1526-632X&amp;rft.issn=1526-632X&amp;rft.au=GRASSET,%20Leslie&amp;ZEKI%20AL%20HAZZOURI,%20Adina&amp;MILAZZO,%20Floriana&amp;LU,%20Peiyi&amp;ELFASSY,%20Tali&amp;rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée